CYTODRIVE
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Aug 2025)
What this means for you
This application is over — abandoned 04 Aug 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97708951
- Mark type
- Stylized text
- Filed
- 08 Dec 2022
- Published for opposition
- 07 Nov 2023
- Abandoned
- 04 Aug 2025
- Attorney of record
- Olivia Maria Baratta
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders
Owner
- Obsidian Therapeutics, Inc., Cambridge, MA, US
- Obsidian Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 04 Aug 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Aug 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 2 GRANTED
- 05 Dec 2024 — SOU EXTENSION 2 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — SOU EXTENSION 1 GRANTED
- 27 Jun 2024 — SOU EXTENSION 1 FILED
- 27 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Nov 2023 — PUBLISHED FOR OPPOSITION
- 18 Oct 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER